Differential requirement forde novolipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential requirement forde novolipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 63, Issue 6, Pages 1900-1913
Publisher
Wiley
Online
2016-02-25
DOI
10.1002/hep.28508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
- (2016) Lei Li et al. JOURNAL OF HEPATOLOGY
- Progress in the development of fatty acid synthase inhibitors as anticancer targets
- (2015) Genevieve E. Mullen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism
- (2015) Daisaku Yamada et al. HEPATOLOGY
- Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer
- (2015) Junyan Tao et al. Oncotarget
- Dependence of Brown Adipose Tissue Function on CD36-Mediated Coenzyme Q Uptake
- (2015) Courtney M. Anderson et al. Cell Reports
- Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
- (2014) Xin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice
- (2014) Chunmei Wang et al. HEPATOLOGY
- A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver
- (2014) Aras N. Mattis et al. HEPATOLOGY
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- CRISPR-mediated direct mutation of cancer genes in the mouse liver
- (2014) Wen Xue et al. NATURE
- Mutational landscape of HCC—the end of the beginning
- (2014) Augusto Villanueva et al. Nature Reviews Clinical Oncology
- Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities
- (2014) Sumera Rizvi et al. SEMINARS IN LIVER DISEASE
- Regulation of lipoprotein lipase by Angptl4
- (2014) Wieneke Dijk et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Arylpiperazines as fatty acid transport protein 1 (FATP1) inhibitors with improved potency and pharmacokinetic properties
- (2013) Tetsuyoshi Matsufuji et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cellular Fatty Acid Metabolism and Cancer
- (2013) Erin Currie et al. Cell Metabolism
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Incidence and mortality trends for biliary tract cancers in Austria
- (2013) Matthias Pinter et al. LIVER INTERNATIONAL
- SLC27 fatty acid transport proteins
- (2013) Courtney M. Anderson et al. MOLECULAR ASPECTS OF MEDICINE
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Lipid metabolism in cancer
- (2012) Claudio R. Santos et al. FEBS Journal
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Cholangiocarcinomas can originate from hepatocytes in mice
- (2012) Biao Fan et al. JOURNAL OF CLINICAL INVESTIGATION
- How cancer metabolism is tuned for proliferation and vulnerable to disruption
- (2012) Almut Schulze et al. NATURE
- Cancer Cell Metabolism: One Hallmark, Many Faces
- (2012) Jason R. Cantor et al. Cancer Discovery
- Targeted Therapies for Hepatocellular Carcinoma
- (2011) Augusto Villanueva et al. GASTROENTEROLOGY
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
- (2011) Jesper B. Andersen et al. GASTROENTEROLOGY
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2,
- (2011) Coral Ho et al. HEPATOLOGY
- Lipoprotein Lipase Links Dietary Fat to Solid Tumor Cell Proliferation
- (2011) N. B. Kuemmerle et al. MOLECULAR CANCER THERAPEUTICS
- FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase
- (2010) Alaric Falcon et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Cholangiocarcinoma: Update and future perspectives
- (2010) Manuela Gatto et al. DIGESTIVE AND LIVER DISEASE
- Fatty acid synthase as a potential therapeutic target in cancer
- (2010) Richard Flavin et al. Future Oncology
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Lipoprotein lipase: from gene to obesity
- (2009) Hong Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
- (2009) Toshiro Migita et al. JNCI-Journal of the National Cancer Institute
- Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
- (2009) R. C. Kane et al. ONCOLOGIST
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Silencing of Hepatic Fatty Acid Transporter Protein 5in VivoReverses Diet-induced Non-alcoholic Fatty Liver Disease and Improves Hyperglycemia
- (2008) Holger Doege et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now